23 C
New York
Saturday, June 6, 2026

Tag: date

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health launches Oliv18™, a USDA and EU certified whole olive polyphenol supplement targeting cardiovascular and antioxidant categories.

Academy Sports + Outdoors Announces Quarterly Cash Dividend

KATY, Texas, June 5, 2026 /PRNewswire/ -- Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (Nasdaq: ASO) announced today that on June 4, 2026,...

Eos Energy Stockholders Approve All Proposals at 2026 Annual Meeting

Increased share authorization provides the capital structure flexibility to fund the planned Frontier Power USA Investment
Increased share authorization provides the capital structure flexibility to fund the planned Frontier Power USA Investment

La Rosa Holdings Corp. Reports 17% Year-Over-Year Revenue Growth to $68.5 Million for Fiscal 2025

Gross Profit Increased 17% Year-Over-Year to $7.0 Million in 2025
Gross Profit Increased 17% Year-Over-Year to $7.0 Million in 2025

AMASS Brands Group Secures First U.S. Distribution Partner for AMASS Electrolyte Mixers

Great Lakes Wine & Spirits, One of the Midwest’s Most Established Distribution Networks, to Launch AMASS Electrolyte Mixers Across Michigan

Ocean Power Technologies Announces Pricing of $10,000,000 Registered Direct Offering Priced At A Premium to Market

MONROE TOWNSHIP, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 25,000,000 shares of the Company’s common stock together with common warrants to purchase up to 25,000,000 shares of common stock in a registered direct offering at a combined purchase price of $0.40 per share of common stock and accompanying common warrant. The offering was priced at a premium to yesterday’s closing price. The common warrants will be exercisable on the six month anniversary of the date of issuance at an exercise price of $0.40 per share and will expire 6 years from the initial date of exercise.

Nasdaq Confirms Turbo Energy’s Compliance With Minimum Stockholders’ Equity Requirement

Recognition follows approximately $5 million in strategic capital raises and continued execution of Turbo Energy's global AI-driven energy infrastructure growth strategy
Recognition follows approximately $5 million in strategic capital raises and continued execution of Turbo Energy's global AI-driven energy infrastructure growth strategy

Making Sustainability Count on World Environment Day: How Beko Focuses on Lowering Water and Energy Consumption from Factories to Homes

ISTANBUL, June 5, 2026 /PRNewswire/ -- Beko, a leading home appliances company, is marking World Environment Day by highlighting a suite of technologies designed...

Orla Mining Reports Resumption of Operations at Camino Rojo

VANCOUVER, BC, June 5, 2026 /CNW/ - Orla Mining Ltd. (TSX: OLA; NYSE: ORLA) ("Orla" or the "Company") is pleased to report that the...

Pines of Sarasota Healthcare, LLC Provides Notice Following Data Security Incident

SARASOTA, Fla., June 5, 2026 /PRNewswire/ -- Pines of Sarasota Healthcare, LLC experienced a data security incident that involved personal and / or protected...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

Cellebrite Announces Upcoming Investor Events on June 10, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDate